đ° Eceptor News
Eceptor News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eceptor. Real-time updates on events, politics, business and more.
May 7, 2024
Case study details a 27-year-old woman with schizoaffective disorder and fibromyalgia who used high-potency cannabis to alleviate pain but experienced adverse psychiatric effects. A month-long diet lowering free glutamate improved her pain, mental health, and allowed her to quit cannabis, highlighting the risks of cannabis self-medication for pain management.
May 7, 2024
Researchers compared SNPs in the vitamin D receptor (VDR) gene between mild and severe COVID-19 patients.
May 4, 2024
Researchers at the University of Toronto have found naturally occurring compounds in the gut that can be harnessed to reduce inflammation and other symptoms of digestive issues.
May 2, 2024
Whether aspirin decreases the risk of invasive cancer events among survivors of breast cancer.
May 1, 2024
National Institutes of Health researchers and collaborators have discovered over 100 new regions of the human genome, also known as genomic loci, that appear to influence a person's blood pressure.
May 1, 2024
Researchers at the University of Toronto have found a way to better control the preclinical generation of key neurons depleted in Parkinson's disease, pointing toward a new approach for a disease with no cure and few effective treatments.
April 30, 2024
The associations between lifestyle, genetic factors, and human longevity.
April 26, 2024
Researchers reviewed the impact of cinnamon, curcumin, and resveratrol on oxidative stress and inflammation in type 2 diabetes patients, highlighting their potential to improve metabolic regulation and reduce complications.
April 26, 2024
A new paper by Dana-Farber Cancer Institute scientists lays the foundation for targeted therapies to inhibit activation of nuclear factor kappa B (NF-ÎșB), a transcription factor that plays a role in various autoimmune and inflammatory diseases and cancers.
April 25, 2024
People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.